Enobia Pharma

Enobia Pharma

Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round

N/A

Acquisition
Total Funding000k
Notes (0)
More about Enobia Pharma
Made with AI
Edit

Enobia operates in the mental health and wellness sector, providing an extensive online therapy platform that specializes in Cognitive Behavioral Therapy (CBT). The company serves individuals seeking mental health support, including those dealing with conditions such as ADHD, hypophosphatasia, and Oppositional Defiant Disorder (ODD). Enobia's market includes both direct consumers and healthcare providers looking for effective, evidence-based therapeutic solutions. The business model is subscription-based, where clients pay for access to therapy sessions, personalized guidance from licensed therapists, and a variety of mental health resources. Revenue is generated through these subscriptions as well as potential partnerships with healthcare institutions. Enobia's unique selling proposition lies in its comprehensive, evidence-based CBT programs and the convenience of online access, making mental health support more accessible and affordable.

Keywords: Cognitive Behavioral Therapy, online therapy, mental health, ADHD, hypophosphatasia, ODD, personalized guidance, subscription-based, evidence-based, healthcare partnerships.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo